The publisher's Medical Devices sector report, 'Aesthetic Injectables Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Aesthetic Injectables pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Aesthetic injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Aesthetic injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Aesthetic Injectables under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Aesthetic Injectables and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Aesthetic Injectables under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Aesthetic Injectables - Pipeline Products under Development by Companies
6 Aesthetic Injectables- Recent Developments
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc
- Acro Biomedical Co Ltd
- Advanced Aesthetic Technologies Inc
- Aeon Astron Corporation
- Aesthetic Medical Device
- Allergan Aesthetics
- Almirall Ltd
- Beijing MeiYan KongJian Technology Co Ltd
- BioPlus Co Ltd
- Bioxis Pharmaceuticals
- BMG Pharma SpA
- Bmi Korea Co Ltd
- CellPraxis
- Celltrix AB
- Collplant Biotechnologies Ltd
- Dexlevo Inc
- Dongkook Pharmaceutical Co Ltd
- EternoGen Aesthetics LLC
- Fillmed Laboratoires
- G2GBIO Inc
- Galderma SA
- Genzyme Corp
- Hallura Ltd
- Histogen Inc
- Hugel Inc
- Innovia LLC
- inSoma Bio Inc
- Inventage Lab Inc
- Jinwoo Bio Co Ltd
- Juvenis Ltd
- Khorionyx SA
- Laboratoires Vivacy SAS
- LG Chem Ltd
- LifeSprout Inc
- Medytox Inc
- Merz North America Inc
- Mesoestetic Pharma Group SL
- Moma Therapeutics Inc
- N8 Medical LLC
- Oligo Medic Inc
- PB&B SA
- Peptron Inc
- PetVivo Holdings Inc
- Q-Med AB
- RepliCel Life Sciences Inc
- Samyang Biopharmaceuticals Corp
- Sebana Medical Ltd
- Shanghai Haohai Biological Technology Co Ltd
- Shin Poong Pharm Co Ltd
- Silk Medical Aesthetics Inc
- Sinclair Pharma Ltd
- Sofregen Medical Inc
- SunMax Biotechnology Co Ltd
- TEI Biosciences Inc
- Tempo Therapeutics Inc
- Teoxane SA
- Tetratherix Pty Ltd
- Tissueform Inc
- University of California Santa Barbara
- University of Missouri